FGL2 and neoplasm: In addition, FGL2 overexpression can skew macrophages and other activated antigen-presenting cells (APCs) in the tumor microenvironment from an inflammatory (M 1) or neoplastic (M0) phenotype to an immunosuppressive (M2) phenotype (23).